Trial Profile
Perioperative effects of inhaled long acting beta2 adrenergic agonist/long acting muscarinic antagonist in patients with untreated COPD requiring surgery for lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2020
Price :
$35
*
At a glance
- Drugs Umeclidinium/vilanterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 20 Apr 2020 Status changed from active, no longer recruiting to completed.
- 12 Sep 2019 Status changed from recruiting to active, no longer recruiting.
- 08 May 2017 Status changed from not yet recruiting to recruiting.